↓ Skip to main content

Polatuzumab Vedotin: First Global Approval

Overview of attention for article published in Drugs, July 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
4 X users
patent
3 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
139 Dimensions

Readers on

mendeley
178 Mendeley
Title
Polatuzumab Vedotin: First Global Approval
Published in
Drugs, July 2019
DOI 10.1007/s40265-019-01175-0
Pubmed ID
Authors

Emma D. Deeks

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 178 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 36 20%
Student > Master 20 11%
Researcher 18 10%
Student > Bachelor 17 10%
Other 13 7%
Other 15 8%
Unknown 59 33%
Readers by discipline Count As %
Chemistry 27 15%
Medicine and Dentistry 26 15%
Biochemistry, Genetics and Molecular Biology 24 13%
Pharmacology, Toxicology and Pharmaceutical Science 16 9%
Agricultural and Biological Sciences 6 3%
Other 15 8%
Unknown 64 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2023.
All research outputs
#3,085,337
of 25,837,817 outputs
Outputs from Drugs
#406
of 3,500 outputs
Outputs of similar age
#60,409
of 361,665 outputs
Outputs of similar age from Drugs
#6
of 43 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,500 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,665 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.